首页> 外文OA文献 >Synthesis and in vitro Antitumor Potency of (Cyclohexane-1,2-Diamine)Platinum(II) Complexes with Aminotris(Methylenephosphonic Acid) as Bone-Seeking Ligand
【2h】

Synthesis and in vitro Antitumor Potency of (Cyclohexane-1,2-Diamine)Platinum(II) Complexes with Aminotris(Methylenephosphonic Acid) as Bone-Seeking Ligand

机译:顺铂的合成及其体外抗肿瘤作用。 (环己烷-1,2-二胺)铂(II)配合物 以氨基三(亚甲基膦酸)为骨配体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In order to develop platinum complexes with selective activity in primary and secondary bonemalignancies and with the aim to optimize antitumor activity, platinum(II) complexes withaminotris(methylenephosphonic acid) as bone-seeking (osteotropic) ligand have been synthesized,characterized and tested in the cisplatin-sensitive ovarian carcinoma cell line CH1. As non-leaving diamineligands, which are decisive for the cellular processing of DNA adducts, cis-R,S-cyclohexane-1,2-diamine,trans-S,S-cyclohexane-1,2-diamine and trans-R,R-cyclohexane-1,2-diamine have been used, resulting incomplexes 1, 2, and 3, respectively. The cytotoxicity of the complexes under investigation decreases in theorder 3 > 2 > 1 which is in accord with structure-activity relationships with other (cyclohexane-1,2-diamine)platinum(II) and platinum(IV) complexes: Both trans complexes (2 and 3) display a higher in vitropotency than the corresponding cis isomer (I), with the trans-R,R isomer (3) being the most active in thisseries. In comparison to the analogous (cyclohexane-1,2-diamine)platinum(II) complexes withbis(phosphonomethyl)aminoacetic acid as osteotropic carrier ligand, the cytotoxicity of 1-3 was found to be1.5 – 2 fold higher, which is explainable by a different coordination mode of the phosphonic acid ligands(acetato versus phosphonato).
机译:为了开发在原发性和继发性骨恶性肿瘤中具有选择性活性的铂配合物,并以优化抗肿瘤活性为目的,已合成,表征和测试了以氨基三(亚甲基膦酸)为骨寻找(促骨性)配体的铂(II)配合物。顺铂敏感性卵巢癌细胞系CH1。作为决定DNA加合物细胞加工的决定性非残留二胺配体,顺式-R,S-环己烷-1,2-二胺,反式-S,S-环己烷-1,2-二胺和反式-R,R已经使用了-环己烷-1,2-二胺,分别形成了复合物1、2和3。所研究的复合物的细胞毒性以3> 2> 1的顺序降低,这与与其他(环己烷-1,2-二胺)铂(II)和铂(IV)配合物的结构-活性关系相符:两种反式配合物( 2和3)显示出比相应的顺式异构体(I)更高的体外效能,其中反式R,R异构体(3)在该系列中最活跃。与以双(膦酰基甲基)氨基乙酸为亲骨载体配体的类似(环己烷-1,2-二胺)铂(II)配合物相比,发现1-3的细胞毒性高1.5-2倍,这是可以解释的通过膦酸配体的不同配位模式(乙酰基对膦酸基)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号